Trump's Medicare Part B drug cost plan could move forward, particularly if Democrats win control of the House.
Observers are divided over whether the Trump administration's moves to allow states to sidestep certain aspects of the Affordable Care Act will ultimately harm the marketplace and the vulnerable people who shop for coverage there.
The caravan of Central American migrants making its way north may well determine the future of healthcare in America.
The CMS and drug companies have different ideas on what kind of price information consumers should have and how they should access it.
A roundup of recent coverage of Medicaid work requirements and expansion in select states sheds light on the current state of work requirements in the U.S.
An analysis of brand-name prescription drug prices shows it's been business as usual for drugmakers, with far more price hikes than cuts. The number of increases slowed somewhat and were not quite as steep as in past years.
Baltimore, Chicago, Columbus and Cincinnati sued the Trump administration over its regulatory dismantling of the Affordable Care Act, claiming that federal actions are already overtaxing their health departments.
Last week's most popular healthcare stories were packed with policy news. The CMS worked through the Fourth of July week, making changes to several payment programs. Meanwhile, other providers are amping up the push for value-based care, and the Trump administration slashed another ACA program.
President Donald Trump can change his policy of separating children from their undocumented migrant families, but he can never undo the damage already inflicted on thousands of innocent children.
Thousands of physicians have descended on Chicago for the American Medical Association's annual meeting. Medicaid and drug prices are also hot topics for this week.
The U.S. clung to its health insurance gains last year, an unexpected outcome after President Donald Trump's repeated attempts to dismantle the Obama-era coverage expansion, according to a major government survey released Tuesday.
President Donald Trump is planning an executive order to ban Planned Parenthood from the Title X family planning grant program, according to a White House aide. The consequences could be far-reaching for other safety-net clinics.